Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
about
Growth factors for treating diabetic foot ulcersGrowth factors for treating diabetic foot ulcersDebridement of diabetic foot ulcersKeratinocyte-Secreted Heat Shock Protein-90alpha: Leading Wound Reepithelialization and ClosureQuality Randomized Clinical Trials of Topical Diabetic Foot Ulcer Healing AgentsChallenges in the Treatment of Chronic Wounds.Diabetes: foot ulcers and amputationsLiterature review on the management of diabetic foot ulcerStem cell therapy for critical limb ischemia: what can we learn from cell therapy for chronic wounds?Biomaterials and Nanotherapeutics for Enhancing Skin Wound HealingTissue engineering for bone regeneration and osseointegration in the oral cavityAntimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healingNovel anti-microbial peptide SR-0379 accelerates wound healing via the PI3 kinase/Akt/mTOR pathwayThe management of neuropathic ulcers of the foot in diabetes by shock wave therapy.Noncontact, low-frequency ultrasound therapy enhances neovascularization and wound healing in diabetic mice.Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcersSuccessful methods of treating leg ulcers. The tried and true, plus the novel and new.Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.Local wound care in diabetic foot complications. Aggressive risk management and ulcer treatment to avoid amputation.Phase I study of H5.020CMV.PDGF-beta to treat venous leg ulcer disease.A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment.Pharmacotherapy of lower limb diabetic ulcers.New treatments in ulcer healing and wound infection.Developments in wound care for difficult to manage wounds.Present and new techniques and devices in the treatment of DFU: a critical review of evidence.Adenoviral-mediated gene transfer in wound healing.Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer.The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials.State-of-the-art treatment of chronic venous disease.Diabetic foot ulcers. Pathophysiology, assessment, and therapyModulating the stem cell niche for tissue regeneration.Becaplermin gel in the treatment of diabetic neuropathic foot ulcersInhibition of stromal cell-derived factor-1α further impairs diabetic wound healing.Platelet Rich Plasma: Efficacy in Treating Trophic Ulcers in Leprosy.Debridement of diabetic foot ulcers.Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alphaA dynamic regulator: the role of growth factors in tissue repair.Specific growth factors and the healing of chronic wounds.Prospective randomized feasibility trial to assess the use of rhPDGF-BB in treatment of distal radius fracturesA fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice
P2860
Q24186333-56387CF8-42B4-45E7-BD3B-BA562881C23EQ24235049-1103559B-0F32-4121-A282-3209E08309B0Q24240958-BFAFB160-A70F-4126-9E3E-2FC3E894BA7DQ26748509-AE542F9E-7265-49D8-ADAA-63FC1B6F6E9EQ26753837-419B7105-4963-4AED-B940-B7661138585DQ26784576-8B52E143-04F9-4580-BEEC-394033207EC9Q26852609-71A856F9-0780-4988-BF5A-5611683BB160Q26865025-C886E9FA-CF11-4994-82C8-886DF5DDE854Q27022877-14DF9881-8E8D-4881-B11C-C802254285FDQ28077978-52B285EE-6B4E-4515-B8B8-F2819C9D1DEAQ28087194-F8B64143-E346-4160-8A85-14E406C78E2EQ28478087-6A7CB364-86F7-42CB-888C-09A6CCDE081AQ28541612-76C19F7B-FB84-41E3-A39C-E86319DBCE7DQ30489094-0A28F608-248B-464E-A8E0-59B258798259Q30648334-C906B777-5E89-44FF-9202-AE5AE929BB18Q33480699-27B4923E-4E94-4800-AE5D-78714B641E38Q33639553-67C1791E-72F0-47B7-94C3-B45143C1606DQ33649275-C64EA1E7-CE70-44F3-B3DF-3FE5B87A6A2BQ33694565-19387AB3-CDDE-4198-90DC-0AAB7B0770A5Q33713069-96607DC3-D976-48B4-89B2-EC3F3239AB31Q33788802-74D017D2-5879-4E70-AB14-2AE032EF731CQ33968152-2EB2C64A-592D-42B0-9B13-F31D6C71950CQ34072007-6C930CE4-8D55-4B5C-B99B-4CAB30091661Q34101516-A15D3F72-9BDC-41B0-A228-E08FBED0BF46Q34137019-A3087C60-A69A-4EBE-8D75-F32084EBF7A4Q34156753-95518529-5060-4C25-B87F-D042615F20ACQ34156759-EA45CBCC-133D-4047-B9A9-C417044C0BFAQ34167850-07691C13-7817-4E92-8C2B-AADB7385886AQ34180286-CBB5B4C2-8F34-48E7-A0AA-848D3E883221Q34277724-7880A238-97BA-49E3-822C-6892668DD3FDQ34432431-14026768-76B8-4492-AD0A-B450C76FEC3FQ34595282-450BA9A9-E7F1-4335-869E-D2230F67A11AQ34679918-47779D34-B04C-427F-8C93-CC4CBF2A3002Q34680039-967CC855-02DD-4DB8-B9D3-005F3CE7DD3EQ35041888-A91F34D8-7706-448B-99FE-F893288D0584Q35088035-D3FD17F5-37E7-429E-80B4-4F80A8E42265Q35215284-5E8869F4-4E5D-49AA-9D8E-E375AF3A4538Q35215303-D63F46C9-20F6-4A30-B0DF-542630CD24ADQ35410145-C6A7D59A-32F8-4987-851F-67F3AE99C222Q35484843-5C05F633-5B97-4E0C-9263-1E4EBA578415
P2860
Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Efficacy and safety of a topic ...... controlled double-blind study.
@ast
Efficacy and safety of a topic ...... controlled double-blind study.
@en
Efficacy and safety of a topic ...... telet-derived growth factor-BB
@nl
type
label
Efficacy and safety of a topic ...... controlled double-blind study.
@ast
Efficacy and safety of a topic ...... controlled double-blind study.
@en
Efficacy and safety of a topic ...... telet-derived growth factor-BB
@nl
prefLabel
Efficacy and safety of a topic ...... controlled double-blind study.
@ast
Efficacy and safety of a topic ...... controlled double-blind study.
@en
Efficacy and safety of a topic ...... telet-derived growth factor-BB
@nl
P2093
P356
P1433
P1476
Efficacy and safety of a topic ...... controlled double-blind study.
@en
P2093
P304
P356
10.2337/DIACARE.21.5.822
P407
P577
1998-05-01T00:00:00Z